NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nosis Bio

Nosis Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.nosisbio.com/

Last Round

Grant

Jul 18, 2023

Total Funding Raised

$13M

Company Overview

Nosis Bio is a biotechnology company that develops a drug delivery platform using artificial intelligence to create cell-targeted RNA medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

RNA therapeuticsdrug discovery platformAI drug discoverycell-targeted deliverygene silencinggenerative AIbiotech platformin vivo validationphysics-aware AIprecision medicinein silico drug designdrug deliverybiotech R&DAI-native biotechligand design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nosis Bio Comparables

Compare Nosis Bio with similar companies based on industry and business-model similarity.

Nosis Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gensaic
84%
Bonito Biosciences
83%
Vivatides Therapeutics
81%

Nosis Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 18, 2023
SeedMar 1, 2023

Key People

Founding team and executive leadership

Seth Myers

Co-Founder CTO

Founding Team

Jim Martineau

Co-Founder CEO

Founding Team

Nosis Bio Investors

Notable investors and investment history

Nosis Bio investors
InvestorRounds
AlleyCorpSeed
Cystic Fibrosis FoundationSeed, Grant
Madrona Venture GroupSeed
Sahsen VenturesSeed
KdT VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2023

    $2M grant from the Cystic Fibrosis Foundation.

  • Mar 1, 2023

    $11M round with participation from Madrona Venture Group.

Nosis Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nosis Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nosis Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range21
Year Founded2021
Last FundingJul 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.